AKR1B10 has an overall sensitivity and specificity of 78% and 85%, respectively, for diagnosing HCC, and it appears more sensitive than alpha-fetoprotein (AFP) for detecting early-stage HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.